Evidence map›Paper›PMID 37306789›Full record

ArticleDiscover oncology2023

Identification of Piezo1 as a potential target for therapy of colon cancer stem-like cells.

Rong Li, Dongmei Wang, Huijuan Li, Xianhua Lei, Weilian Liao, Xiao-Yu Liu

Open access · goldAbstract read
In one paragraph

Article in Discover oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Piezo1/ITGB1 Synergizes With CaCancer medicine · 2025
    Article
  7. Review
  8. Activating membrane receptors with ultrasound.Nature biomedical engineering · 2025
    Article
  9. Article
  10. Piezo1-related physiological and pathological processes in glioblastoma.Frontiers in cell and developmental biology · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rong LiDepartment of Pathology, Ganzhou Cancer Hospital, No. 19, HuaYuan Qian Road, Ganzhou, Jiangxi, China. lirong911@126.com.
Dongmei WangDepartment of Pathology, Ganzhou Cancer Hospital, No. 19, HuaYuan Qian Road, Ganzhou, Jiangxi, China.
Huijuan LiDepartment of Pathology, Ganzhou Cancer Hospital, No. 19, HuaYuan Qian Road, Ganzhou, Jiangxi, China.
Xianhua LeiDepartment of Pathology, Ganzhou Cancer Hospital, No. 19, HuaYuan Qian Road, Ganzhou, Jiangxi, China.
Weilian LiaoDepartment of Pathology, Ganzhou Cancer Hospital, No. 19, HuaYuan Qian Road, Ganzhou, Jiangxi, China.
Xiao-Yu LiuSchool of Medicine, Southern University of Science and Technology, 1088 Xueyuan Avenue, Shenzhen, Guangdong, China. liuxiaoyu2017@163.com.
Ganzhou People's Hospital · CNSouthern University of Science and Technology · CN

Funding

Funding Science and Technology Plan of Jiangxi Provincial Health and Family Planning Commission 202140804National Natural Science Foundation of China 82003108
6 · The paper itself

Abstract

Colon cancer is a common malignancy of the digestive tract. Colon cancer stem-like cells (CCSCs) are theoretically one of the key drivers of the initiation, relapse, metastasis, and chemo-resistance of colon tumors. Piezo1 is a mechanosensitive cationic channel protein involved in cancer progression. However, little is known regarding the possible role of Piezo1 in maintaining the stemness of CCSCs. In this study, we found that Piezo1 was highly expressed in CD133

Indexed as

CalciumColon cancer stem-like cellsNFAT1Piezo1Stemness

Identifiers

PMID37306789
PMCPMC10260724
OpenAlexW4380264648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.